AbbVie Inc. is 282.6x more valuable than ATAI Life Sciences N.V. by market capitalization ($402.35 B vs $1.42 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ATAI | ABBV |
|---|---|---|
| Market cap | $1.42 B | $402.35 B |
| US-listed rank | #2389 | #31 |
| Revenue (latest FY) | $308.00K | $61.16B |
| Net income (latest FY) | -$149.27M | $4.23B |
| Net margin | -48464.0% | 6.9% |
| P/E (trailing FY) | - | 95.2 |
| SEC filings | 320 | 1,008 |
AbbVie Inc. is 282.6x more valuable than ATAI Life Sciences N.V. by market capitalization ($402.35 B vs $1.42 B).
In their latest fiscal years, ATAI Life Sciences N.V. reported $308.00K in revenue while AbbVie Inc. reported $61.16B.
Full pages: ATAI Life Sciences N.V. and AbbVie Inc., or browse the full rankings.